(Q36653635)

15 August 2017

1 reference

title

DNA ploidy and prostate-specific antigen as prognostic factors in clinically resectable prostate cancer (English)

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

15 August 2017

1 reference

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

5 November 2022

author name string

O'Toole RV

2

1 reference

15 August 2017

R. A. Badalament

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710533

5 November 2022

R. V. O'Toole

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710533

5 November 2022

D. C. Young

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710533

5 November 2022

J. R. Drago

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710533

5 November 2022

language of work or name

English

0 references

publication date

1 June 1991

1 reference

15 August 2017

15 June 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1710533

full work available at URL

5 November 2022

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

5 November 2022

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

5 November 2022

1 reference

15 August 2017

67

1 reference

15 August 2017

3014-3023

1 reference

15 August 2017

12

1 reference

The prognostic value of DNA ploidy combined with histologic substaging for incidental carcinoma of the prostate gland

15 August 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819910615%2967%3A12%3C3014%3A%3AAID-CNCR2820671215%3E3.0.CO%3B2-U

Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819910615%2967%3A12%3C3014%3A%3AAID-CNCR2820671215%3E3.0.CO%3B2-U

Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819910615%2967%3A12%3C3014%3A%3AAID-CNCR2820671215%3E3.0.CO%3B2-U

Clinical utility of serum prostatic acid phosphatase measurements for detection (screening), diagnosis, and therapeutic monitoring of prostatic carcinoma; assessment of monoclonal and polyclonal enzymes and radioimmunoassays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819910615%2967%3A12%3C3014%3A%3AAID-CNCR2820671215%3E3.0.CO%3B2-U

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

21 January 2018

2

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Radical perineal prostatectomy for palpable, clinically localized, non-obstructive cancer: experience at the Johns Hopkins Hospital 1909-1963

5 November 2022

3

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Trends in patterns of care for prostatic cancer, 1974-1983: results of surveys by the American College of Surgeons

5 November 2022

4

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate

5 November 2022

5

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Relative value of prostate-specific antigen and prostatic acid phosphatase in diagnosis and management of adenocarcinoma of prostate. Ohio State University experience

5 November 2022

6

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

The value of serum prostate specific antigen determinations before and after radical prostatectomy

5 November 2022

7

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients

5 November 2022

8

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.

5 November 2022

9

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Prognostic factors in localized prostatic carcinoma.

5 November 2022

11

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Prostatic carcinoma cell DNA content measured by flow cytometry and its relation to clinical outcome

5 November 2022

12

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

DNA distribution patterns of prostatic tissue obtained at time of transurethral resection

5 November 2022

14

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence

5 November 2022

15

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Relationship of DNA content to conventional prognostic factors in clinically localised carcinoma of the prostate

5 November 2022

17

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Prognostic significance of DNA ploidy in carcinoma of prostate

5 November 2022

19

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis

5 November 2022

20

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

5 November 2022

Investigative Urology

22

17

159

Wang

1979

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Technical and statistical improvements for flow cytometric DNA analysis of paraffin-embedded tissue

5 November 2022

29

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Staging errors in clinically localized prostatic cancer

5 November 2022

31

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Gleason histologic grading of prostatic carcinoma. Correlations between biopsy and prostatectomy specimens

5 November 2022

32

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Patterns of progression in prostate cancer

5 November 2022

33

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Prostatic acid phosphatase: its current clinical status

5 November 2022

34

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

5 November 2022

36

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers

5 November 2022

37

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Tumour markers in prostatic carcinoma. A comparison of prostate-specific antigen with acid phosphatase

5 November 2022

38

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Carcinoma of the prostate: clinical and pathological staging and prognosis.

5 November 2022

39

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia

5 November 2022

43

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Frozen section lymph node analysis in pelvic lymphadenectomy for prostate cancer

5 November 2022

45

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Proceedings: Etiology, epidemiology, and pathology of prostatic cancer.

5 November 2022

47

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Cancer of the prostate: epidemiology and aetiology

5 November 2022

48

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

Racial differences in cancer incidence: the significance of age-specific patterns

5 November 2022

49

1 reference

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(19910615)67:12%3C3014::AID-CNCR2820671215%3E3.0.CO;2-U

5 November 2022

Identifiers

10.1002/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U

1 reference

15 August 2017

1 reference